Try our Advanced Search for more refined results

Biopharma Co. Blasts 'Excessive' Fee Bid In Board Pay Case

By Rose Krebs ( September 22, 2022, 4:31 PM EDT) -- After striking a tentative deal to settle a Delaware Chancery suit he filed over alleged "grossly excessive" director pay, an investor plaintiff is now seeking an "excessive" payday for his attorneys, Sage Therapeutics Inc. has told the court....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!